Arcturus Therapeutics (NASDAQ:ARCT) reported its Q1 earnings results on Tuesday, May 9, 2023 at 04:01 PM.
Here’s what investors need to know about the announcement.
Earnings
Arcturus Therapeutics beat estimated earnings by 3016.67%, reporting an EPS of $1.87 versus an estimate of $0.06.
Revenue was up $75.04 million from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $3.35 which was followed by a 30.13% increase in the share price the next day.
Here’s a look at Arcturus Therapeutics’s past performance:
| Quarter | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|
| EPS Estimate | 0.98 | -1.81 | -1.90 | -1.44 |
| EPS Actual | 4.33 | -1.33 | -0.82 | -1.94 |
| Revenue Estimate | 72.68M | 3.42M | 2.09M | 6.30M |
| Revenue Actual | 160.29M | 13.37M | 27.09M | 5.24M |
To track all earnings releases for Arcturus Therapeutics visit their earnings calendar here.
This article was generated by Benzinga’s automated content engine and reviewed by an editor.
